5-aryl-3-(8-azabicyclo (3.2.2) oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as -5HT4 receptor ligands
Compound of general formula (I)in which R1 represents an alkyl or cycloalkylmethyl group, X1 represents a hydrogen or halogen atom or an alkoxy group, or alternatively OR1 and X1 together represent an -OCH2O-, -O(CH2)2-, -O(CH2)3-, -O(CH2)2O- or -(CH2)3O- group, X2 represents a hydrogen atom or an a...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Compound of general formula (I)in which R1 represents an alkyl or cycloalkylmethyl group, X1 represents a hydrogen or halogen atom or an alkoxy group, or alternatively OR1 and X1 together represent an -OCH2O-, -O(CH2)2-, -O(CH2)3-, -O(CH2)2O- or -(CH2)3O- group, X2 represents a hydrogen atom or an amino group, X3 represents a hydrogen or halogen atom, and R2 represents a hydrogen atom, an optionally substituted alkyl group, an optionally substituted phenylalkyl group or a group -(CH2)nCO-Z in which n represents a number from 1 to 6 and Z represents a 1-piperidyl group. Therapeutic application. |
---|